249 related articles for article (PubMed ID: 23567012)
1. Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.
Heinemann L; Freckmann G; Koschinsky T
J Diabetes Sci Technol; 2013 Mar; 7(2):542-7. PubMed ID: 23567012
[TBL] [Abstract][Full Text] [Related]
2. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197.
Freckmann G; Schmid C; Baumstark A; Pleus S; Link M; Haug C
J Diabetes Sci Technol; 2012 Sep; 6(5):1060-75. PubMed ID: 23063032
[TBL] [Abstract][Full Text] [Related]
3. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
Pashkov V; Kotvitska A; Harkusha A
Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
[TBL] [Abstract][Full Text] [Related]
4. Medical device regulation for manufacturers.
McAllister P; Jeswiet J
Proc Inst Mech Eng H; 2003; 217(6):459-67. PubMed ID: 14702983
[TBL] [Abstract][Full Text] [Related]
5. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
[TBL] [Abstract][Full Text] [Related]
6. Obtaining reimbursement in France and Italy for new diabetes products.
Schaefer E; Schnell G; Sonsalla J
J Diabetes Sci Technol; 2015 Jan; 9(1):156-61. PubMed ID: 25550411
[TBL] [Abstract][Full Text] [Related]
7. Neither protective nor harmonized: the crossborder regulation of medical devices in the EU.
Jarman H; Rozenblum S; Huang TJ
Health Econ Policy Law; 2021 Jan; 16(1):51-63. PubMed ID: 32631465
[TBL] [Abstract][Full Text] [Related]
8. [Medical devices industry: the problem of clinical evaluation reports].
Egbosimba D
Ann Biol Clin (Paris); 2019 Oct; 77(5):514-516. PubMed ID: 31466939
[TBL] [Abstract][Full Text] [Related]
9. CE marking--what does it really mean?
Bentley D
J Tissue Viability; 1999 Jan; 9(1):11-5. PubMed ID: 10480978
[TBL] [Abstract][Full Text] [Related]
10. Diabetes device reimbursement in the EU-5.
Schäfer E; Schnell G; Bobáková T
J Diabetes Sci Technol; 2013 Jul; 7(4):1084-92. PubMed ID: 23911192
[TBL] [Abstract][Full Text] [Related]
11. Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review.
Beck A; Retèl VP; Bhairosing PA; van den Brekel M; van Harten WH
Health Policy; 2019 Dec; 123(12):1185-1198. PubMed ID: 31718855
[TBL] [Abstract][Full Text] [Related]
12. How does medical device regulation perform in the United States and the European union? A systematic review.
Kramer DB; Xu S; Kesselheim AS
PLoS Med; 2012; 9(7):e1001276. PubMed ID: 22912563
[TBL] [Abstract][Full Text] [Related]
13. ["Medical devices and European regulations"].
Fleur F
Ann Pharm Fr; 1997; 55(2):73-6. PubMed ID: 9181704
[TBL] [Abstract][Full Text] [Related]
14. Lot-to-lot variability of test strips and accuracy assessment of systems for self-monitoring of blood glucose according to ISO 15197.
Baumstark A; Pleus S; Schmid C; Link M; Haug C; Freckmann G
J Diabetes Sci Technol; 2012 Sep; 6(5):1076-86. PubMed ID: 23063033
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
Fraser AG; Daubert JC; Van de Werf F; Estes NA; Smith SC; Krucoff MW; Vardas PE; Komajda M;
Eur Heart J; 2011 Jul; 32(13):1673-86. PubMed ID: 21572115
[TBL] [Abstract][Full Text] [Related]
17. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
[TBL] [Abstract][Full Text] [Related]
18. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
Campillo-Artero C
Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
[TBL] [Abstract][Full Text] [Related]
19. Reimbursement programs and health technology assessment for diabetes devices and supplies: a Canadian perspective.
Cheung RY; Mui V
J Diabetes Sci Technol; 2015 May; 9(3):706-10. PubMed ID: 25697719
[TBL] [Abstract][Full Text] [Related]
20. Materials vigilance and traceability.
Tracol P
Orthop Traumatol Surg Res; 2016 Feb; 102(1 Suppl):S95-103. PubMed ID: 26822532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
